Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects
EMA Orders New Warning About Risk Of Venous Thromboembolism, While FDA And Health Canada Begin Safety Review (Posted by Tom Lamb at DrugInjuryWatch.com) In recent months there has been a flurry of activity by…
-
Multaq Cardiovascular Deaths Overshadow Earlier Liver Injury Concerns For Drug Regulators
FDA Now Looking At Two-Fold Increase In CV Deaths, Strokes, And Heart Failure Hospitalizations From PALLAS Study Data (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Multaq (dronedarone) – Information on Increase in Heart-Related…
-
Sanofi Heart Medication Multaq Has Constantly Been On FDA’s Radar During 2010 And 2011
Liver Failure, Renal Impairment, And Cardiovascular Problems Cited As Potential Signals Of Risk Involving Multaq (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Health Canada announced on July 21, 2011 that it is reviewing…
-
Multaq Update: European Safety Review Expanded To Cardiovascular Side Effects Risk In July 2011
EMA And FDA Already Had Sanofi Issue A "Dear Doctor" Letter About Liver Failure In January 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: The FDA announced on July 21, 2011 that it…
-
Chantix Anti-Smoking Pill: How Significant Is The Heart Risk; Should Chantix Be Recalled
Canadian Medical Journal Article Suggests That The June 2011 Label Change By FDA And Pfizer Is Not Sufficient Measure (Posted by Tom Lamb at DrugInjuryWatch.com) As some may recall, in mid-June 2011 the FDA issued…
-
Yasmin / YAZ MDL: First Trial Moved From September 2011 To January 2012 Per Plaintiffs’ Request
A Pulmonary Embolism Case Is Selected By Judge Herndon; More Than 6600 Lawsuits Filed Against Bayer As Of May 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: The January 9, 2012 Sims v. Bayer "bellwether",…
-
Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots
Just As It Did In 2010 Label Change, Bayer Contends New Medical Studies Are Less Reliable Than Other VTE Evidence (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: New research suggests that women who…
-
Ortho Evra “Black-Box” Warning About Risks Of Blood Clots Added To Package Insert In March 2011
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called…
-
730 NuvaRing Lawsuits Filed As Of December 31, 2010 Per Merck Annual Report
610 Cases Were In Federal Court NuvaRing MDL And 110 Complaints Filed In New Jersey State Court (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: First NuvaRing Lawsuit Trials Against Merck Are Currently Scheduled…
-
YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011
A Pulmonary Embolism Bellwether Case Will Be Followed By Gallbladder And Venous Thromboembolic Lawsuit Trials (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: The January 9, 2012 Sims v. Bayer "bellwether", or test, trial has been postponed…